EGA
ACHV icon

Eagle Global Advisors’s Achieve Life Sciences ACHV Stock Holding History

Eagle Global Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-58
Closed -$65K – 372
2016
Q3 		$65K Sell
58
-8
-12% -$12.8K ﹤0.01% 350
2016
Q2 		$146K Hold
66
– – ﹤0.01% 337
2016
Q1 		$100K Hold
66
– – ﹤0.01% 350
2015
Q4 		$176K Buy
66
+42
+175% +$178K 0.01% 328
2015
Q3 		$120K Buy
+24
New +$145K ﹤0.01% 345

Other funds holding ACHV

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Eagle Global Advisors's ACHV Position: Q4 2016 in Review

Eagle Global Advisors sold out of Achieve Life Sciences (ACHV) in Q4 2016, closing a stake of 58 shares — an estimated $65K sold.

Eagle Global Advisors first reported a position in ACHV in Q3 2015 and held it in 5 quarters. The position peaked at $176K in Q4 2015. 29 funds tracked by Wall St. Rank hold ACHV as of Q4 2016.

  • Eagle Global Advisors reported no remaining Achieve Life Sciences position as of Q4 2016 after selling out during the quarter.
  • Eagle Global Advisors sold 58 Achieve Life Sciences shares in Q4 2016, an estimated $65K.
  • Eagle Global Advisors first reported a position in Achieve Life Sciences in Q3 2015 and held it in 5 quarters.
  • Eagle Global Advisors's Achieve Life Sciences position peaked at $176K in Q4 2015.
  • 29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2016.

Based on Eagle Global Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.